Journal of Clinical Endocrinology & Metabolism, Vol 81, 3328-3334, Copyright © 1996 by Endocrine Society

ARTICLES

Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy

S Muttukrishna, PA Fowler, L George, NP Groome and PG Knight
School of Animal and Microbial Sciences, University of Reading, Whiteknights, United Kingdom.

The main objective of this study was to determine whether activin A concentrations in peripheral blood fluctuate during the normal human menstrual cycle and pregnancy. Blood samples were collected longitudinally from five regularly cycling volunteers (22-30 yr) throughout a spontaneous menstrual cycle and cross-sectionally from normal pregnant women attending the antenatal clinic (8-38 weeks gestation: 3-20 subjects/time point). Total (i.e. bound plus free) activin A concentrations were measured using a recently developed two- site enzyme immunoassay that employs an analyte denaturation/oxidation step to eliminate interference due to endogenous activin-binding proteins. During the menstrual cycle, mean serum activin A levels varied in a biphasic manner (by ANOVA, P = 0.02), with highest levels around midcycle (approximately 220 pg/mL) and the late luteal/early follicular phase (approximately 310 pg/mL) and nadirs in both midfollicular (approximately 125 pg/mL) and midluteal (approximately 120 pg/mL) phases. Between the mid- to late luteal phase, the activin A level increased progressively (approximately 2.5-fold; P < 0.05), whereas inhibin A, estradiol, and progesterone all decreased progressively (approximately 10-fold; P < 0.001). During pregnancy, serum activin A levels were much higher than those in nonpregnant subjects, with a value of 2.12 +/- 0.31 ng/mL recorded in week 8. Levels remained at approximately 2 ng/mL between weeks 8-24, but increased thereafter to reach 25.5 +/- 6 ng/mL by week 38, a value approximately 100 times greater than that during the normal menstrual cycle. Serum activin A levels during pregnancy were significantly correlated with inhibin A (r = 0.69; P < 0.001), estradiol (r = 0.55; P < 0.001), and progesterone (r = 0.74; P < 0.001) values. Gel permeation chromatography indicated that all of the detectable activin A in human follicular fluid, pregnancy serum, and term placental extract eluted with an apparent molecular mass between 70-200 kDa, indicating that little, if any, free activin (molecular mass, 25 kDa) is present in these samples. Although these results support a possible endocrine role for circulating activin A during the human menstrual cycle and pregnancy, the observation that all detectable activin A is associated with binding protein(s) raises questions about its relative bioavailability for action on peripheral target cells.

This article has been cited by other articles:

				M. Myers, S. van den Driesche, A. S McNeilly, and W C. Duncan Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin in vitro J. Endocrinol., November 1, 2008; 199(2): 201 - 212. [Abstract] [Full Text] [PDF]

				P. Ciarmela, E. Wiater, and W. Vale Activin-A in Myometrium: Characterization of the Actions on Myometrial Cells Endocrinology, May 1, 2008; 149(5): 2506 - 2516. [Abstract] [Full Text] [PDF]

				K. Y Arai and T. Nishiyama Developmental Changes in Extracellular Matrix Messenger RNAs in the Mouse Placenta During the Second Half of Pregnancy: Possible Factors Involved in the Regulation of Placental Extracellular Matrix Expression Biol Reprod, December 1, 2007; 77(6): 923 - 933. [Abstract] [Full Text] [PDF]

				M. Myers, E. Gay, A. S. McNeilly, H. M. Fraser, and W. C. Duncan In Vitro Evidence Suggests Activin-A May Promote Tissue Remodeling Associated with Human Luteolysis Endocrinology, August 1, 2007; 148(8): 3730 - 3739. [Abstract] [Full Text] [PDF]

				S. Mandang, U. Manuelpillai, and E. M Wallace Oxidative stress increases placental and endothelial cell activin A secretion J. Endocrinol., March 1, 2007; 192(3): 485 - 493. [Abstract] [Full Text] [PDF]

				I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]

				C Bearfield, E Jauniaux, N Groome, I L Sargent, and S Muttukrishna The secretion and effect of inhibin A, activin A and follistatin on first-trimester trophoblasts in vitro Eur. J. Endocrinol., June 1, 2005; 152(6): 909 - 916. [Abstract] [Full Text] [PDF]

				D. D. Elsholz, V. Padmanabhan, R. L. Rosenfield, P. R. Olton, D. J. Phillips, and C. M. Foster GnRH agonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulating inhibin-B and activin-A Hum. Reprod., December 1, 2004; 19(12): 2748 - 2758. [Abstract] [Full Text] [PDF]

				S. Muttukrishna, C. Bearfield, J. Johns, and E. Jauniaux Inhibin, activin, follistatin, activin receptors and {beta}-glycan gene expression in the villous tissue of miscarriage patients Mol. Hum. Reprod., November 1, 2004; 10(11): 793 - 798. [Abstract] [Full Text] [PDF]

				C. M. Foster, P. R. Olton, M. S. Racine, D. J. Phillips, and V. Padmanabhan Sex differences in FSH-regulatory peptides in pubertal age boys and girls and effects of sex steroid treatment Hum. Reprod., July 1, 2004; 19(7): 1668 - 1676. [Abstract] [Full Text] [PDF]

				L. Cobellis, F. M. Reis, S. Luisi, S. Danero, L. Pirtoli, G. Scambia, and F. Petraglia High Concentrations of Activin A in the Peritoneal Fluid of Women With Epithelial Ovarian Cancer Reproductive Sciences, May 1, 2004; 11(4): 203 - 206. [Abstract] [PDF]

				D. S. Tannetta, S. Muttukrishna, N. P. Groome, C. W. G. Redman, and I. L. Sargent Endothelial Cells and Peripheral Blood Mononuclear Cells Are a Potential Source of Extraplacental Activin A in Preeclampsia J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5995 - 6001. [Abstract] [Full Text] [PDF]

				M. P. Plevyak, G. M. Lambert-Messerlian, A. Farina, N. P. Groome, J. A. Canick, and H. M. Silver Concentrations of Serum Total Activin A and Inhibin A in Preterm and Term Labor Patients: A Cross-Sectional Study Reproductive Sciences, May 1, 2003; 10(4): 231 - 236. [Abstract] [PDF]

				S. Muttukrishna, E. Jauniaux, N. Greenwold, H. McGarrigle, S. Jivraj, S. Carter, S. Elgaddal, N. Groome, and L. Regan Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages Hum. Reprod., December 1, 2002; 17(12): 3072 - 3078. [Abstract] [Full Text] [PDF]

				C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752. [Abstract] [Full Text] [PDF]

				F. M. Reis, D. D'Antona, and F. Petraglia Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy Endocr. Rev., April 1, 2002; 23(2): 230 - 257. [Abstract] [Full Text] [PDF]

				G. P. Risbridger, J. F. Schmitt, and D. M. Robertson Activins and Inhibins in Endocrine and Other Tumors Endocr. Rev., December 1, 2001; 22(6): 836 - 858. [Abstract] [Full Text] [PDF]

				T. Eldar-Geva, I.M. Spitz, N.P. Groome, E.J. Margalioth, and R. Homburg Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome Hum. Reprod., December 1, 2001; 16(12): 2552 - 2556. [Abstract] [Full Text] [PDF]

				P. A. Fowler, T. Sorsa, W. J. Harris, P. G. Knight, and H. D. Mason Relationship between follicle size and gonadotrophin surge attenuating factor (GnSAF) bioactivity during spontaneous cycles in women Hum. Reprod., July 1, 2001; 16(7): 1353 - 1358. [Abstract] [Full Text] [PDF]

				J. A. Keelan, R. L. Zhou, L. W. Evans, N. P. Groome, and M. D. Mitchell Regulation of Activin A, Inhibin A, and Follistatin Production in Human Amnion and Choriodecidual Explants by Inflammatory Mediators Reproductive Sciences, September 1, 2000; 7(5): 291 - 296. [Abstract] [PDF]

				S. Muttukrishna, R.A. North, J. Morris, J.-C. Schellenberg, R.S. Taylor, J. Asselin, W. Ledger, N. Groome, and C.W.G. Redman Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia Hum. Reprod., July 1, 2000; 15(7): 1640 - 1645. [Abstract] [Full Text] [PDF]

				S. Muttukrishna, T. Child, G.M. Lockwood, N.P. Groome, D.H. Barlow, and W.L. Ledger Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women Hum. Reprod., March 1, 2000; 15(3): 549 - 556. [Abstract] [Full Text] [PDF]

				F. Debieve, S. Beerlandt, C. Hubinont, and K. Thomas Gonadotropins, Prolactin, Inhibin A, Inhibin B, and Activin A in Human Fetal Serum from Midpregnancy and Term Pregnancy J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 270 - 274. [Abstract] [Full Text]

				H.M. Buckler, W.R. Robertson, A. Anderson, M. Vickers, and A. Lambert Ovulation induction with low dose alternate day recombinant follicle stimulating hormone (Puregon) Hum. Reprod., December 1, 1999; 14(12): 2969 - 2973. [Abstract] [Full Text] [PDF]

				C.P. Lau, W.L. Ledger, N.P. Groome, D.H. Barlow, and S. Muttukrishna Dimeric inhibins and activin A in human follicular fluid and oocyte-cumulus culture medium Hum. Reprod., October 1, 1999; 14(10): 2525 - 2530. [Abstract] [Full Text] [PDF]

				T. R. Kumar, G. Palapattu, P. Wang, T. K. Woodruff, I. Boime, M. C. Byrne, and M. M. Matzuk Transgenic Models to Study Gonadotropin Function: The Role of Follicle-Stimulating Hormone in Gonadal Growth and Tumorigenesis Mol. Endocrinol., June 1, 1999; 13(6): 851 - 865. [Abstract] [Full Text]

				A.E. O'Connor, J.R. McFarlane, S. Hayward, T. Yohkaichiya, N.P. Groome, and D.M. de Kretser Serum activin A and follistatin concentrations during human pregnancy: a cross-sectional and longitudinal study Hum. Reprod., March 1, 1999; 14(3): 827 - 832. [Abstract] [Full Text] [PDF]

				L. M. Foulds, D. M. de Kretser, P. Farnworth, D. Buttress, G. Jenkin, N. P. Groome, and J. R. McFarlane Ovine Allantoic Fluid Contains High Concentrations of Activin A: Partial Dissociation of Immunoactivity and Bioactivity Biol Reprod, August 1, 1998; 59(2): 233 - 240. [Abstract] [Full Text]

				F. Petraglia, P. Florio, S. Luisi, R. Gallo, A. Gadducci, P. Viganò, A. M. Di Blasio, A. R. Genazzani, and W. Vale Expression and Secretion of Inhibin and Activin in Normal and Neoplastic Uterine Tissues. High Levels of Serum Activin A in Women with Endometrial and Cervical Carcinoma J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1194 - 1200. [Abstract] [Full Text]

				D. S. McConnell, Q. Wang, P. M. Sluss, N. Bolf, R. H. Khoury, A. L. Schneyer, A. R. Midgley Jr., N. E. Reame, W. F. Crowley Jr., and V. Padmanabhan A Two-Site Chemiluminescent Assay for Activin-Free Follistatin Reveals That Most Follistatin Circulating in Men and Normal Cycling Women Is in an Activin-Bound State J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 851 - 858. [Abstract] [Full Text]

				Q. Guo, T. R. Kumar, T. Woodruff, L. A. Hadsell, F. J. DeMayo, and M. M. Matzuk Overexpression of Mouse Follistatin Causes Reproductive Defects in Transgenic Mice Mol. Endocrinol., January 1, 1998; 12(1): 96 - 106. [Abstract] [Full Text]

				C. K. Welt, G. Lambert-Messerlian, W. Zheng, W. F. Crowley Jr., and A. L. Schneyer Presence of Activin, Inhibin, and Follistatin in Epithelial Ovarian Carcinoma J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3720 - 3727. [Abstract] [Full Text] [PDF]

				F. Petraglia, S. Luisi, C. Benedetto, M. Zonca, P. Florio, E. Casarosa, A. Volpe, S. Bernasconi, and A. R. Genazzani Changes of Dimeric Inhibin B Levels in Maternal Serum Throughout Healthy Gestation and in Women with Gestational Diseases J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2991 - 2995. [Abstract] [Full Text] [PDF]

				M. Birdsall, W. Ledger, N. Groome, H. Abdalla, and S. Muttukrishna Inhibin A and Activin A in the First Trimester of Human Pregnancy J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1557 - 1560. [Abstract] [Full Text] [PDF]